跳至主要内容
临床试验/IRCT20200728048242N1
IRCT20200728048242N1已完成2 期

Comparison of clinical efficacy of Intranasal administration of midazolam and ketamine in managing pain and distress associated with peripheral IV access in children presenting to emergency departments of IUMS

Iran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 10 years(—)
性别
All

入选标准

  • 1 to 10 years-old Children
  • Emergency department or wards admission
  • Needing IV access for diagnostic and therapeutic interventions

排除标准

  • Patients with critical or emergency conditions, or in other words, have level 1 triage and are treated in the resuscitation room
  • All cases in which parents do not consent to sedation and analgesia prior to peripheral intravenous access
  • All patients with a history of allergies to ketamine or midazolam
  • Age less than one year or over 10 years
  • Existence of serious underlying heart disease including heart failure, electrical heart disorders, congenital heart defects
  • Presence of advanced liver or kidney disease, including renal failure or dialysis, history of kidney or liver transplantation, congenital metabolic disorders
  • Children with cerebral palsy, cystic fibrosis and epilepsy
  • Congenital or acquired jaw and facial abnormalities

研究者

相似试验